Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3090551)

Published in Hepatol Int on December 28, 2010


Gonzalo Sapisochin1, Itxarone Bilbao, Cristina Dopazo, Luis Castells, Jose Luis Lázaro, Roberto Rodríguez, Mireia Caralt, Laia Blanco, Joaquin Balsells, Ramón Charco

Author Affiliations

1: Department of Hepatobiliopancreatic Surgery and Transplantation, Hospital Universitario Vall D'Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain, sapisochin@me.com.

Articles cited by this

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl (2008) 1.97

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation (2005) 1.94

Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transpl (2008) 1.78

Cancers complicating organ transplantation. N Engl J Med (1990) 1.57

Rapamycin: an anti-cancer immunosuppressant? Crit Rev Oncol Hematol (2005) 1.50

Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int (2006) 1.45

The changing pattern of posttransplant malignancies. Transplant Proc (1991) 1.42

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Transplantation (2004) 1.39

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation (2002) 1.33

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28

Posttransplant malignancies. Transplant Proc (1999) 1.27

The problem of cancer in organ transplant recipients: an overview. Transplant Sci (1994) 1.22

Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12

Late mortality after orthotopic liver transplantation. Am J Surg (2001) 1.12

De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant (2004) 1.09

De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl (2005) 1.07

Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery (1995) 1.07

De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer (1997) 1.06

Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation (2005) 1.05

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology (1990) 1.05

The role of mTOR inhibitors in the management of posttransplant malignancy. Transplantation (2009) 1.04

De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00

Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol (2005) 0.99

Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl (2001) 0.98

Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl (2002) 0.97

Non-lymphoid cancer after liver transplantation. Hepatogastroenterology (1997) 0.94

Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant (2009) 0.93

De novo malignancy following liver transplantation: a single-center study. Transplant Proc (1993) 0.93

De novo malignancies in liver transplantation. Transplant Proc (2003) 0.85

[Characterization of de novo malignancies in liver transplantation]. Gastroenterol Hepatol (2003) 0.81

Post-transplant lymphoproliferative disorders. Pathol Oncol Res (1997) 0.79

Articles by these authors

Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl (2005) 2.04

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59

Pancreatogastrostomy with gastric partition after pylorus-preserving pancreatoduodenectomy versus conventional pancreatojejunostomy: a prospective randomized study. Ann Surg (2008) 1.43

High-performance capillary electrophoretic method for the quantification of 5-methyl 2'-deoxycytidine in genomic DNA: application to plant, animal and human cancer tissues. Electrophoresis (2002) 1.42

Curative laparoscopic resection for pancreatic neoplasms: a critical analysis from a single institution. J Gastrointest Surg (2007) 1.40

[One thousand liver transplants. Hospital Clinic i Provincial de Barcelona (Spain)]. Cir Esp (2005) 1.39

Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg (2008) 1.16

Promoter DNA hypermethylation and gene repression in undifferentiated Arabidopsis cells. PLoS One (2008) 1.09

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06

Predictive factors for early mortality following liver transplantation. Clin Transplant (2003) 1.01

Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg (2001) 0.98

Acetylated H4 histone and genomic DNA methylation patterns during bud set and bud burst in Castanea sativa. J Plant Physiol (2009) 0.97

Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation (2008) 0.96

Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer. Ann Surg Oncol (2008) 0.95

A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells. Clin Cancer Res (2013) 0.94

Laboratory colonization of Anopheles pseudopunctipennis (Diptera: Culicidae) without forced mating. C R Biol (2007) 0.94

Genomic DNA methylation-demethylation during aging and reinvigoration of Pinus radiata. Tree Physiol (2002) 0.93

Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl (2010) 0.92

Combined proteomic and transcriptomic analysis identifies differentially expressed pathways associated to Pinus radiata needle maturation. J Proteome Res (2010) 0.92

Liver transplantation in HIV-HCV coinfected patients: a case-control study. Transplantation (2007) 0.91

Successful transplantation of organs from a donor with postneurosurgical meningitis caused by Escherichia coli. Transplantation (2012) 0.90

Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol (2005) 0.90

Dynamics of DNA methylation and Histone H4 acetylation during floral bud differentiation in azalea. BMC Plant Biol (2010) 0.90

A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C. Transpl Int (2005) 0.89

Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol (2012) 0.88

HPCE quantification of 5-methyl-2'-deoxycytidine in genomic DNA: methodological optimization for chestnut and other woody species. Plant Physiol Biochem (2008) 0.88

Statistical analyses: possible reasons for unreliability of source tracking efforts. Appl Environ Microbiol (2005) 0.87

Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma. J Hepatobiliary Pancreat Sci (2011) 0.87

Phase-change related epigenetic and physiological changes in Pinus radiata D. Don. Planta (2002) 0.87

Transcriptome analysis of chestnut (Castanea sativa) tree buds suggests a putative role for epigenetic control of bud dormancy. Ann Bot (2011) 0.86

Variations in DNA methylation, acetylated histone H4, and methylated histone H3 during Pinus radiata needle maturation in relation to the loss of in vitro organogenic capability. J Plant Physiol (2010) 0.85

Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients. Int Immunopharmacol (2006) 0.85

Epigenetic characterization of the vegetative and floral stages of azalea buds: dynamics of DNA methylation and histone H4 acetylation. J Plant Physiol (2009) 0.84

Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg (2010) 0.84

Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia. Psychiatry Res (2009) 0.83

Our experience in liver transplantation in patients over 65 yr of age. Clin Transplant (2008) 0.83

Safety of bevacizumab in metastatic breast cancer patients undergoing surgery. Eur J Cancer (2011) 0.83

FK506 in the maturation of dendritic cells. Haematologica (2002) 0.82

Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature. Liver Transpl (2012) 0.81

Liver transplantation in hepatocellular carcinoma. Transpl Int (2005) 0.81

Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antivir Ther (2006) 0.81

Anopheles of Bolivia: new records with an updated and annotated checklist. C R Biol (2008) 0.80

Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation. Liver Int (2012) 0.80

Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure. Liver Int (2013) 0.79

Visceral leishmaniasis among liver transplant recipients: an overview. Liver Transpl (2008) 0.79

Early induced protein 1 (PrELIP1) and other photosynthetic, stress and epigenetic regulation genes are involved in Pinus radiata D. don UV-B radiation response. Physiol Plant (2012) 0.79

Liver biopsy-related infection in liver transplant recipients: A current matter of concern? Liver Transpl (2014) 0.78

Feeding the economics of obesity in the EU in a healthy way. Eur J Health Econ (2010) 0.78

Proteomic analysis of Pinus radiata needles: 2-DE map and protein identification by LC/MS/MS and substitution-tolerant database searching. J Proteome Res (2008) 0.78

Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis. World J Gastroenterol (2009) 0.78

Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation. Liver Transpl (2011) 0.77

Optimization of liver grafts in liver retransplantation: a European single-center experience. Surgery (2008) 0.77

Impact of prior portosystemic shunt procedures on outcome of liver transplantation. Surgery (2005) 0.77

Epigenetic and physiological effects of gibberellin inhibitors and chemical pruners on the floral transition of azalea. Physiol Plant (2010) 0.77

Promotion of flowering in azaleas by manipulating photoperiod and temperature induces epigenetic alterations during floral transition. Physiol Plant (2011) 0.77

Changes in polyamine concentration associated with aging in Pinus radiata and Prunus persica. Tree Physiol (2004) 0.77

Proteomic profiling of Tectona grandis L. leaf. Proteomics (2012) 0.76

Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients. Transplantation (2012) 0.76

[Krukenberg's tumor as the first clinical manifestation of fibrolamellar hepatocarcinoma]. Gastroenterol Hepatol (2008) 0.76

[Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery]. Cir Esp (2006) 0.76

Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues? Ann Hepatol (2011) 0.75

Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study. Liver Transpl (2014) 0.75

[Therapeutic management of juxtapapillary duodenal diverticulum]. Cir Esp (2012) 0.75

Low plasma levels of antithrombin III in the early post-operative period following pediatric liver transplantation: should they be replaced? A single-center pilot study. Pediatr Transplant (2014) 0.75

Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation. Transplantation (2016) 0.75

Quantitative analysis of ornithine decarboxylase mRNA by reverse transcription-PCR with the LightCycler system. Clin Chem (2002) 0.75

Simple and inexpensive method for the reliable determination of additions of soybean proteins in heat-processed meat products: an alternative to the AOAC official method. J Agric Food Chem (2005) 0.75

[Drugs in the European Union: the health-market complex]. Gac Sanit (2005) 0.75

Xanthine oxidoreductase and preservation injury in human liver transplantation. Transplantation (2004) 0.75

A Pinus radiata AAA-ATPase, the expression of which increases with tree ageing. J Exp Bot (2004) 0.75

[Giant sacrococcygeal teratoma in twin pregnancy]. Ginecol Obstet Mex (2014) 0.75

[Hepatic angiomyolipoma in two patients infected with hepatitis C virus]. Gastroenterol Hepatol (2007) 0.75

Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation. Transpl Int (2003) 0.75

Reinvigoration of Pinus radiata is associated with partial recovery of juvenile-like polyamine concentrations. Tree Physiol (2003) 0.75

[Compendium of the first 100 years of scientific articles, writings, documents, editorials, and historical facts about medicine in the light of the times of the Boletín Científico de la Asociación Médica de Puerto Rico]. Bol Asoc Med P R (2003) 0.75

Tobacco policies in the European Union: a need for state and continental harmonisation? Eur J Health Econ (2007) 0.75